RankAlpha logo
Back to Rankings

AKTS

Aktis OncologyN/A
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
AKTS vs peer average
50/100
AKTS vs. peer average (N/A vs. C)
Grade spread
A 2 · B 2 · C 1 · D 1 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

DBVT is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $1.05B

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerDBVTDBV
AKTS
Aktis Oncology
DBVT
DBV
Grade
N/A
B
Momentum
77
31
Value
-
41
Sentiment
-
100
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Unrated
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs DBVT

AKTS / DBVT
Grade Position
In line
AKTS vs. peer average (N/A vs. C)
50/100
Momentum
77
AKTS
Value
-
-
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AKTS
1
DBVT
DBV Technologies SA ADR
B
80/100
-
2
EYPT
EyePoint Inc Common
C
60/100
-
3
XERS
Xeris Biopharma Holdings Inc Common
B
80/100
-
4
EVO
Evotec SE ADR
A
100/100
-
5
MNKD
MannKind Corp Common
A
100/100
-
DBVT is the first peer returned for this comparison set.